+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)



Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)



Annals of Internal Medicine 113(1): 14-20



The objective was to determine whether oral corticosteroids can prevent early deterioration in patients with acquired immunodeficiency syndrome (AIDS)-related Pneumocystis carinii pneumonia. It was designed as a prospective, double-blind, placebo-controlled, randomized trial. Included patients were having their first P. carinii pneumonia episode, had no other known active pulmonary pathology, had no contraindication for corticosteroids, received no anti-P. carinii pneumonia medications for more than 48 hours, and had oxygen saturation by pulse oximetry of 85% or more and less than 90% at rest or a 5-percentage-point decrease in oxygen saturation with exercise while breathing room air. Consenting subjects were randomly assigned to prednisone, 60 mg/d for 7 days, followed by a progressive tapering over 14 days or to an identical placebo. Early deterioration, the endpoint of the trial was defined as a 10% decrease in baseline oxygen sturation on day 3 or thereafter. The cases of patients developing early deterioration were considered to be failures of treatment; the code was then broken, and the patient's treatment was left to the judgment of the treating physician. Sequential analysis was done with the primary variable being development of early deterioration. The trial was terminated 5 April 1989 on the basis of the sequential analysis when a total of nine episodes of early deterioration had occurred in the first 37 patients at an overall significance level of P = 0.0136. A total of 8 of 19 placebo-treated patients (42.1%) developed early deterioration compared with only 1 of 18 patients (5.6%) treated with corticosteroids. Baseline characteristics were not statistically different between the two treatment groups. The adjusted odds ratio for the treatment effect was 5.87 (95% CI, 1.27 to 27.4). The adjusted point estimates for the probability of early deterioration in the placebo and corticosteroid groups were 43% and 12%, respectively. All 8 patients in the placebo group developing early deterioration recovered rapidly with addition of corticosteroid treatment. The single patient with early deterioration in the corticosteroid group died on day 6 from overwhelming P. carinii pneumonia, as documented at autopsy. The corticosteroid group had an increased exercise tolerance on day 7 that persisted at day 30. Oral corticosteroids prevent early deterioration and increase exercise tolerance in patients with moderately severe AIDS-related P. carinii pneumonia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007165157

Download citation: RISBibTeXText

PMID: 2190515

DOI: 10.7326/0003-4819-113-1-14


Related references

Dramatic improvement of severe Pneumocystis carinii pneumonia by corticosteroids despite lack of antipneumocystis therapy in acquired immunodeficiency syndrome. Nihon Kokyuki Gakkai Zasshi 38(11): 885-890, 2001

Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. New England Journal of Medicine 323(21): 1444-1450, 1990

Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet 1(8548): 1477-1479, 1987

Role of systemic corticosteroids in patients with overwhelming pneumocystis carinii pneumonia in acquired immunodeficiency syndrome. Chest 98(2 SUPPL): 101S, 1990

Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome (AIDS). Harefuah 141(11): 983-7, 1009, 1008, 2002

Oral corticosteroids in patients with mild Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome (AIDS). Tubercle and Lung Disease 74(3): 173-179, 1993

Clinical characteristics and diagnosis of Pneumocystis carinii pneumonia (PCP) in patients with the acquired immunodeficiency syndrome (AIDS). Zhonghua Jie He He Hu Xi Za Zhi 25(8): 475-477, 2002

The effect of inhaled pentamidine on the prevention of pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome aids. American Review of Respiratory Disease 137(4 PART 2): 120, 1988

Treatment of acute Pneumocystis carinii pneumonia with corticosteroids in a patient with acquired immunodeficiency syndrome. Critical Care Medicine 17(1): 104-105, 1989

Lung and chest wall mechanics in patients with acquired immunodeficiency syndrome and severe Pneumocystis carinii pneumonia. European Respiratory Journal 10(10): 2343-2350, 1997

Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome (Aids). Chest 87(5): 603-607, 1985

A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. New England Journal of Medicine 323(21): 1451-1457, 1990

Severe neutropenia during pentamidine treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome--New York City. Mmwr. Morbidity and Mortality Weekly Report 33(6): 65-67, 1984

Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome (AIDS). Diagnostic results of transbronchial lung biopsy and bronchoalveolar lavage. Praxis und Klinik der Pneumologie 40(1): 28-32, 1986

Assessment of the complications related to trimethoprim sulfamethoxazole ts and pentamidine p for treatment of pneumocystis carinii pneumonia pcp in patients with acquired immunodeficiency syndrome aids. Clinical & Investigative Medicine 14(4 SUPPL): A114, 1991